Processing your request


please wait...

Case Page

 

Case Status:    DISMISSED    
On or around 04/14/2023 (Date of order of final judgment)

Filing Date: November 14, 2019

According to the Complaint, Lipocine Inc. is a specialty pharmaceutical company that focuses on the development of pharmaceutical products in the area of men’s and women’s health. The Company’s primary development programs are based on oral delivery solutions for poorly bio-available drugs.

The Complaint alleges that during the Class Period, Defendants engaged in a plan, scheme, conspiracy and course of conduct, pursuant to which they knowingly or recklessly engaged in acts, transactions, practices and courses of business which operated as a fraud and deceit upon Plaintiff and the other members of the Class; made various untrue statements of material facts and omitted to state material facts necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading; and employed devices, schemes and artifices to defraud in connection with the purchase and sale of securities.

On February 24, 2020, the Court issued an Order appointing Lead Plaintiff and Counsel. Lead Plaintiff filed an amended Complaint on May 26. Defendants filed a Motion to Dismiss the amended Complaint on July 24.

On April 13, 2023, the Court issued an Order granting Defendants' Motion to Dismiss. The case was dismissed with prejudice.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.